# # Glutamatergic Modulators for Major Depressive Disorder

This project presents a scientific poster prepared for an academic module on emerging therapies. It focuses on glutamatergic antidepressants, particularly NMDA receptor modulators, as novel treatments for Major Depressive Disorder (MDD).

[Vilazodone_Regulatory_Analysis.docx](https://github.com/user-attachments/files/20690582/Vilazodone_Regulatory_Analysis.docx)


## Topics Covered

- Mechanisms of action of glutamatergic agents
- Key clinical trials involving ketamine, esketamine, and other NMDA-targeting drugs
- MADRS response rates and clinical relevance
- Visual summaries of drug efficacy and safety

## Tools Used

- Microsoft PowerPoint
- BioRender
- Literature review from PubMed and academic sources

## Author

Tom Delany  
BSc Biomedical Science, University of Galway  
ðŸ“§ tomdelany04@gmail.com
